For four generations, Rome’s Angelini family has built a $2.5 billion operation with drugs for depression and epilepsy in Europe. Now it’s bought its way into the U.S. market.
In this week’s edition of InnovationRx, we look at Summa Health’s first tech bets, the healthcare leaders on Forbes Veteran 250 list, BioMarin’s acquisition of an early-stage bone disease therapy, and more.
Google says its buying Spirit Airlines’ data for $10 million.
Despite racking up more than $2 billion in losses while sticking to a do-it-yourself strategy, buy-now, pay-later pioneer Affirm is finally profitable—and worth $25 billion.
Chairman and CEO Wang Xingxing’s fortune surged nearly sevenfold to $16 billion as investors bet on China’s leading humanoid robot maker.
Despite billions in revenues, most influencers and their popular channels carry too much “key-person” risk for institutional investors. This UK firm has figured out how to turn viral videos into evergreen products.
This week’s Current Climate newsletter also looks at big funds flowing into long-duration battery makers and the impact of a big proposed cut to NOAA’s budget.
Elon Musk’s DOGE gutted staffing and budgets at NOAA and the National Weather Service early last year. It left fishing fleets, farmers and insurers exposed to the fallout
It would be medical malpractice to continue—and indeed expand—a particularly bad Biden-era healthcare initiative.
Last week, we tracked more than 35 tech funding deals worth over €763 million and over 10 exits, M&A transactions, rumours, and related news stories across Europe.📊 The top three industries that r…